The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Risk of New-Onset Atrial Fibrillation in Relation to Body Mass Index
Abstract
BACKGROUND: Obesity is associated with increased risk of atrial fibrillation (AF), but it is unknown whether the association differs by duration or persistence of AF. It is also unknown to what extent cardiovascular risk factors may mediate this association. METHODS: This population-based case-control study included 425 subjects with new-onset AF and 707 controls. The AF cases were identified through International Classification of Diseases, Ninth Revision codes for inpatient and outpatient visits and verified by medical record review. Medical records provided data on height, weight, and cardiovascular risk factors. RESULTS: On average, AF risk was 3% higher (95% confidence interval [CI], 1%-5%) per unit increment in body mass index (BMI) (calculated as weight in kilograms divided by height in meters squared). For sustained AF (duration > or =6 months), risk was higher by 7% (95% CI, 3%-11%) per unit BMI increment; for intermittent AF (duration > or =8 days or recurrent), 4% (95% CI, 1%-6%); and for transitory AF (duration <8 days), 1% (95% CI, -1% to +4%). Compared with those with normal BMI, the odds ratios for overweight and obese subjects were as follows: overweight, 0.97 (95% CI, 0.68-1.38); obese class 1, 1.18 (95% CI, 0.80-1.73); obese class 2, 1.34 (95% CI, 0.82-2.18); and obese class 3, 2.31 (95% CI, 1.36-3.91) (P = .002 for trend). When diabetes mellitus, a possible mediator, was added to the model, the odds ratio per unit increment of BMI decreased from 1.034 to 1.028. Adjustment for other cardiovascular risk factors including hyperlipidemia and blood pressure did not attenuate the BMI-AF association. CONCLUSIONS: The association with BMI was stronger for sustained AF than for transitory or intermittent AF. The obesity-AF association appears to be partially mediated by diabetes mellitus but minimally through other cardiovascular risk factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1994) · doi:10.1201/9780429246593 · Cited by 40,500
(2000) · PubMed · Cited by 13,173
Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575
An Introduction to the Bootstrap.
Buckland, S. T., Efron, B., & Tibshirani, R. J. (1994) · Biometrics · doi:10.2307/2532810 · Cited by 3,103
Benjamin, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510350050036 · Cited by 2,613
Elevated C-reactive protein levels in overweight and obese adults
Visser, M. (1999) · JAMA · doi:10.1001/jama.282.22.2131 · Cited by 2,494
Feinberg, W. M. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.5.469 · Cited by 2,274
Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study
Lloyd-Jones, D. M., Wang, T. J., Leip, E. P., Larson, M. G., Levy, D., Vasan, R. S., D’Agostino, R. B., Massaro, J. M., Beiser, A., Wolf, P. A., et al. (2004) · Circulation · doi:10.1161/01.cir.0000140263.20897.42 · Cited by 2,041
Krahn, A. D., Manfreda, J., Tate, R. B., Mathewson, F. A. L., & Cuddy, T. E. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80348-9 · Cited by 1,478
Incidence of and risk factors for atrial fibrillation in older adults
Psaty, B. M., Manolio, T. A., Kuller, L. H., Kronmal, R. A., Cushman, M., Fried, L. P., White, R., Furberg, C. D., & Rautaharju, P. M. (1997) · Circulation · doi:10.1161/01.cir.96.7.2455 · Cited by 1,462
Obesity and the risk of new-onset atrial fibrillation
Wang, T. J. (2004) · JAMA · doi:10.1001/jama.292.20.2471 · Cited by 1,427
Inflammation as a risk factor for atrial fibrillation
Aviles, R. J., Martin, D. O., Apperson-Hansen, C., Houghtaling, P. L., Rautaharju, P., Kronmal, R. A., Tracy, R. P., Van Wagoner, D. R., Psaty, B. M., Lauer, M. S., et al. (2003) · Circulation · doi:10.1161/01.cir.0000103131.70301.4f · Cited by 1,425 · cited 1×
“25 GHC enrollment, y 19 (11-29) 19 (11-29) .”
Chung, M. K., Martin, D. O., Sprecher, D., Wazni, O., Kanderian, A., Carnes, C. A., Bauer, J. A., Tchou, P. J., Niebauer, M. J., Natale, A., et al. (2001) · Circulation · doi:10.1161/hc4901.101760 · Cited by 1,375
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary
Fuster, V., Rydén, L. E., Asinger, R. W., Cannom, D. S., Crijns, H. J., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W. W., Lévy, S., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01587-x · Cited by 1,348
The Risk of Myocardial Infarction Associated With Antihypertensive Drug Therapies
Psaty, B. M. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530080036038 · Cited by 1,003
Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study
Stewart, S., Hart, C. L., Hole, D. J., & McMurray, J. J. V. (2001) · Heart · doi:10.1136/heart.86.5.516 · Cited by 661
Body mass index, diabetes, and C-reactive protein among U.S. adults.
Ford, E. S. (1999) · Diabetes Care · doi:10.2337/diacare.22.12.1971 · Cited by 644
Fúster, & Westerling, R. (2001) · Circulation · Cited by 607
ESTIMATING THE PROPORTION OF TREATMENT EFFECT EXPLAINED BY A SURROGATE MARKER
LIN, D. Y., FLEMING, T. R., & DE GRUTTOLA, V. (1997) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19970715)16:13<1515::aid-sim572>3.0.co;2-1 · Cited by 520
Frost, L., Hune, L. J., & Vestergaard, P. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.01.031 · Cited by 428
Psaty, B. M. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.12.1333 · Cited by 301
Blüher, M., Fasshauer, M., Tönjes, A., Kratzsch, J., Schön, M., & Paschke, R. (2005) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2005-872851 · Cited by 193
Incidence of chronic atrial fibrillation in general practice and its treatment pattern
Ruigómez, A., Johansson, S., Wallander, M.-A., & Rodrı́guez, L. A. G. (2002) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00478-4 · Cited by 193
Hospitalizations for atrial fibrillation in the general male population: morbidity and risk factors
Wilhelmsen, L., Rosengren, A., & Lappas, G. (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00902.x · Cited by 184
Heckbert, S. R. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440330066007 · Cited by 109
Yuan, G., Zhou, L., Tang, J., Yang, Y., Gu, W., Li, F., Hong, J., Gu, Y., Li, X., Ning, G., et al. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.10.025 · Cited by 88
Conway, D., Buggins, P., Hughes, E., et al. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.04.070 · Cited by 77
Adiponectin and C-reactive protein in obesity, type 2 diabetes, and monodrug therapy
Putz, D., Goldner, W. S., Bar, R. S., Haynes, W. G., & Sivitz, W. I. (2004) · Metabolism · doi:10.1016/j.metabol.2004.06.013 · Cited by 76
Obesity and the Risk of New-Onset Atrial Fibrillation
Korantzopoulos, P. G., & Kolettis, T. M. (2005) · JAMA · doi:10.1001/jama.293.16.1974-c · Cited by 26
Cited by
Calkins, H., Hindricks, G., Cappato, R., Kim, Y.-H., Saad, E. B., Aguinaga, L., Akar, J. G., Badhwar, V., Brugada, J., Camm, J., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.05.012 · Cited by 2,755
Andrade, J., Khairy, P., Dobrev, D., & Nattel, S. (2014) · Circulation Research · doi:10.1161/circresaha.114.303211 · Cited by 1,187
Calkins, H., Hindricks, G., Cappato, R., Kim, Y.-H., Saad, E. B., Aguinaga, L., Akar, J. G., Badhwar, V., Brugada, J., Camm, J., et al. (2018) · EP Europace · doi:10.1093/europace/eux274 · Cited by 1,164
Alonso, A., Krijthe, B. P., Aspelund, T., Stepas, K. A., Pencina, M. J., Moser, C. B., Sinner, M. F., Sotoodehnia, N., Fontes, J. D., Janssens, A. C. J. W., et al. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.112.000102 · Cited by 882
Global epidemiology of atrial fibrillation
Rahman, F., Kwan, G. F., & Benjamin, E. J. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.118 · Cited by 731
Metadata
- Authors
- Dublin, S.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2006-11-27
- Volume
- 166
- Issue
- 21
- Pages
- 2322
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2145392918
- Cited by
- 266
- References
- 29
- FWCI
- 9.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.